InvestorsHub Logo
Followers 16
Posts 2090
Boards Moderated 0
Alias Born 05/26/2013

Re: None

Friday, 12/28/2018 8:54:06 AM

Friday, December 28, 2018 8:54:06 AM

Post# of 2676
Ladenburg Thinks Zynerba Pharmaceuticals’ Stock Recover to $26
https://www.smarteranalyst.com/brief/ladenburg-thinks-zynerba-pharmaceuticals-stock-is-going-to-recover/

Cantor Fitzgerald analyst Charles Duncan maintained a Buy rating on Zynerba Pharmaceuticals (ZYNE) today and set a price target of $21. The company’s shares opened today at $4.27, close to its 52-week low of $4.12.
https://www.smarteranalyst.com/brief/cantor-fitzgerald-thinks-zynerba-pharmaceuticals-stock-is-going-to-recover-3/


-Buy, Sell and trade stocks at your own risk.
-What I say in my posts are strictly my opinions.
-So do your own DD (Due Diligence) and take your own decisions.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News